Enrichment of multiple myeloma plasma cells for disease monitoring at MGUS and MRD stages
![](https://appliedcells.com/wp-content/uploads/AC_A043.png)
Bone marrow plasma cells characterization is key for diagnosing and monitoring hematologic malignancies, including multiple myeloma (MM). In MM patients, plasma cell numbers can vary, from less than 0.01% to as much as 100% of the total cell population, depending on the stage of the disease. Accurate detection and analysis of plasma cells are especially […]
Enhancing Diagnostic Precision in Multiple Myeloma
![](https://appliedcells.com/wp-content/uploads/AC_WP001-White-paper-cover.png)
Innovative solutions that improve diagnostic precision in multiple myeloma patients have potential to improve patient care and research outcomes. In this study we introduced a streamlined method for isolating CD138+ cells for multiple myeloma (MM) diagnosis and cytogenetic analysis. Using CD138 microbeads and the MARS BAR Flex platform, we achieved high recovery rates, purity, and […]
Efficient CTC enrichment with column-free MARS Bar Platform
![Efficient CTC purification using CD45 depletion with MARS® Bar technology advances cancer research.](https://appliedcells.com/wp-content/uploads/AC_A042.png)
Purifying circulating tumor cells (CTCs) is vital for cancer research advancement and new diagnostic and therapeutic strategies. High-purity CTC isolation provides critical insights into tumor biology, metastasis, and treatment response. CTCs are invaluable for personalized medicine development, biomarker discovery, and therapeutic testing. Here, we introduce a rapid and effective CTC isolation method using CD45 depletion […]
MARS® Ingenuity™ Line of Reagents brochure
![](https://appliedcells.com/wp-content/uploads/apc-resources-brochure-thumb-B017-Ingenuity-large.png)
MARS® Ingenuity™ Reagent kits offer comprehensive solutions for the advancement of global cell therapy research, development and manufacturing. Designed with both Research Use Only (RUO) and GMP-grade reagents, these kits provide a fast and straightforward approach to cell isolation, supporting a wide range of therapies including CAR-T, immune cell-based therapies, stem cell-based therapies, and cancer […]
T cell Isolation using CD3/CD28 microbeads
![Application note showcasing Column-Free CD3/CD28+ T cell Isolation using 50nm Superparamagentic Beads on MARS® Bar](https://appliedcells.com/wp-content/uploads/AC_A041-1024x1024.png)
The success of CAR T cell therapy in blood cancers highlights the need to optimize manufacturing for wider access, and efficient T cell isolation is crucial, impacting therapy effectiveness. Demand for better isolation methods is rising. CD3/CD28 microbeads are gaining attention for simplifying processes and enhancing workflow. They activate a wide range of T cells, […]
AACR 2024: A Novel Automated Platform for Rapid Manufacturing of CAR-T Cells
![AACR 2024 poster introducing A new Automated MARS Platform for Rapid Manufacturing of CAR-T Cells by Applied Cells](https://appliedcells.com/wp-content/uploads/AACR-2024-poster-for-web.png)
Autologous cell therapy using T cells that are genetically modified to express a chimeric antigen receptor (CAR) has yielded durable responses in patients with cancers. However, globally only a small fraction of eligible patients are privileged to receive the treatment. High cost and long manufacturing time contribute to the key limitations prohibiting a broad adoption […]
Column-Free CD14+ Monocyte Isolation using 50nm Superparamagentic Beads on MARS® Bar
![Application note showcasing Column-Free Monocyte Isolation using 50nm Superparamagentic Beads on MARS® Bar](https://appliedcells.com/wp-content/uploads/AC_A039A-Ingenuity-CD14_app-note-graphic.png)
Dendritic cells are professional antigen-presenting cells and they play a key role in the regulation of immune responses. Dendritic cells are widely used as vaccines and drugs for cancer treatment in a large number of trials. Macrophages are essential innate immune cells and when activated, macrophages can mediate the phagocytosis of dangerous cells or materials […]
Column-Free T cell Isolation using 50nm Superparamagentic Beads on MARS® Bar
![Application note showcasing Column-Free T cell Isolation using 50nm Superparamagentic Beads on MARS® Bar](https://appliedcells.com/wp-content/uploads/AC_A040-app-note-1024x1024.png)
The therapeutic efficacy of CAR T cells has been firmly established in hematologic malignancies and the key is to develop a low-cost manufacturing process to enable the wide adoption of the therapy. T cell isolation being upstream process for CAR T cell manufacturing has significant impact on the quality of the T cells and the […]
Improving cell isolation for advanced Stem Cell therapy development
![](https://appliedcells.com/wp-content/uploads/Applied-Cells-Stem-Cell-brochure.png)
Redefining CD138+ Plasma Cell Isolation for Multiple Myeloma Clinical Research
![Brochure summarising benefits of CD138+ Plasma Cell Isolation for Multiple Myeloma Clinical Research with MARS Platform](https://appliedcells.com/wp-content/uploads/Applied-Cells_MM-brochure.png)